Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 64

    1.

    [Malignancies in HIV infected patients: Study of 139 cases.]

    Ramírez-Olivencia G, Valencia-Ortega ME, Martin-Carbonero L, Moreno-Celda V, González-Lahoz J.

    Med Clin (Barc). 2009 Nov 21;133(19):729-35. Epub 2009 Oct 31. Spanish. PMID: 19880148 [PubMed - in process]Related articles

    2.

    Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients.

    Medrano J, Barreiro P, Resino S, Tuma P, Rodríguez V, Vispo E, Labarga P, Madejón A, García-Samaniego J, Jiménez-Nácher I, Martín-Carbonero L, Soriano V.

    Clin Infect Dis. 2009 Nov 1;49(9):1397-401.PMID: 19814621 [PubMed - in process]Related articles

    3.

    Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid.

    Núñez-Fernández C, Martín-Carbonero L, Valencia ME, Aguilera J, García-Samaniego J, Gonzalez-Lahoz J, Soriano V.

    AIDS Res Hum Retroviruses. 2009 Apr;25(4):383-5.PMID: 19320566 [PubMed - indexed for MEDLINE]Related articles

    4.

    Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.

    Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, Rivas P, Albalater M, Blanco F, Moreno V, Vispo E, Soriano V.

    AIDS. 2009 Mar 27;23(6):689-96.PMID: 19262355 [PubMed - in process]Related articles

    5.

    [Hepatitis B in patients with HIV infection.]

    Barreiro P, Martín-Carbonero L, García-Samaniego J.

    Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:71-9. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675. PMID: 19100234 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.

    Vispo E, Barreiro P, Rodriguez-Nóvoa S, Morello J, Labarga P, Martín-Carbonero L, Maida I, García-Gascó P, Soriano V.

    Antivir Ther. 2008;13(4):511-7.PMID: 18672529 [PubMed - indexed for MEDLINE]Related articles

    7.

    Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.

    Vispo E, Barreiro P, Pineda JA, Mira JA, Maida I, Martín-Carbonero L, Rodríguez-Nóvoa S, Santos I, López-Cortes LF, Merino D, Rivero A, Soriano V.

    Antivir Ther. 2008;13(3):429-37.PMID: 18572756 [PubMed - indexed for MEDLINE]Related articles

    8.

    Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.

    Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin-Carbonero L, Barreiro P, Mura MS, Babudieri S, Albertos S, Garcia-Samaniego J, Soriano V.

    Antivir Ther. 2008;13(1):103-7.PMID: 18389904 [PubMed - indexed for MEDLINE]Related articles

    9.

    Emerging drugs for hepatitis C.

    Soriano V, Madejon A, Vispo E, Labarga P, Garcia-Samaniego J, Martin-Carbonero L, Sheldon J, Bottecchia M, Tuma P, Barreiro P.

    Expert Opin Emerg Drugs. 2008 Mar;13(1):1-19. Review.PMID: 18321145 [PubMed - indexed for MEDLINE]Related articles

    10.

    Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome.

    García-Gascó P, Maida I, Blanco F, Barreiro P, Martín-Carbonero L, Vispo E, González-Lahoz J, Soriano V.

    J Antimicrob Chemother. 2008 Mar;61(3):699-704. Epub 2008 Jan 12.PMID: 18192682 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.

    Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V.

    AIDS. 2008 Jan 2;22(1):15-21.PMID: 18090387 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.

    Briz V, Poveda E, del Mar González M, Martín-Carbonero L, González-González R, Soriano V.

    J Antimicrob Chemother. 2008 Feb;61(2):405-10. Epub 2007 Dec 6.PMID: 18063598 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.

    Soriano V, García-Gasco P, Vispo E, Ruiz-Sancho A, Blanco F, Martín-Carbonero L, Rodríguez-Novoa S, Morello J, de Mendoza C, Rivas P, Barreiro P, González-Lahoz J.

    J Antimicrob Chemother. 2008 Jan;61(1):200-5. Epub 2007 Nov 13.PMID: 17999977 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Management and therapy of chronic hepatitis C in HIV.

    Soriano V, Vispo E, Martin-Carbonero L, Labarga P, Garcia-Samaniego J, Barreiro P.

    Curr Opin HIV AIDS. 2007 Nov;2(6):482-8.PMID: 19372931 [PubMed - in process]Related articles

    15.

    Update on the treatment of chronic hepatitis C in HIV-infected patients.

    Soriano V, Barreiro P, Martin-Carbonero L, Vispo E, Garcia-Samaniego J, Labarga P, Gonzalez-Lahoz J.

    AIDS Rev. 2007 Apr-Jun;9(2):99-113. Review.PMID: 17694677 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.

    Labarga P, Soriano V, Vispo ME, Pinilla J, Martin-Carbonero L, Castellares C, Casado R, Maida I, Garcia-Gasco P, Barreiro P.

    J Infect Dis. 2007 Sep 1;196(5):670-6. Epub 2007 Jul 13.PMID: 17674307 [PubMed - indexed for MEDLINE]Related articles

    17.

    Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.

    Soriano V, Miralles C, Berdún MA, Losada E, Aguirrebengoa K, Ocampo A, Arazo P, Cervantes M, de los Santos I, San Joaquín I, Echeverria S, Galindo MJ, Asensi V, Barreiro P, Sola J, Hernandez-Burruezo JJ, Guardiola J, Blanco F, Martin-Carbonero L, García-Samaniego J, Nuñez M; PRESCO Study Group.

    Antivir Ther. 2007;12(4):469-76.PMID: 17668555 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.

    Poveda E, de Mendoza C, Martin-Carbonero L, Corral A, Briz V, González-Lahoz J, Soriano V.

    J Antimicrob Chemother. 2007 Oct;60(4):885-8. Epub 2007 Jul 23.PMID: 17646201 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.

    Núñez M, Mariño A, Miralles C, Berdún MA, Sola J, Hernandez-Burruezo JJ, Galindo MJ, Barreiro P, Martin-Carbonero L, Soriano V.

    J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):439-44. Erratum in: J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):528. Mariño, Angel [corrected to Mariño, Ana]. PMID: 17468669 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.

    Soriano V, Barreiro P, Martín-Carbonero L, Castellares C, Ruiz-Sancho A, Labarga P, Ramos B, Gonzalez-Lahoz J.

    J Infect Dis. 2007 Apr 15;195(8):1181-3. Epub 2007 Mar 2.PMID: 17357055 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...